Periodic Reporting for period 3 - ICOD (Improving COgnition in Down syndrome)

The general ambition of the ICOD project is to develop the first pharmacological therapy of cognitive impairments in Down syndrome (DS) and make it available to patients worldwide.The ICOD project funded by the European Union (EU) (Grant Agreement ID 899986) will fill that gap...